AMBQ
Ambiq MicroN/ADocument history
Earnings documents stored for AMBQ.
Investor releaseQuarter not tagged2026-05-15Earnings Beat: Ambiq Micro, Inc. (NYSE:AMBQ) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Simply Wall St.
Earnings Beat: Ambiq Micro, Inc. (NYSE:AMBQ) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Ambiq Micro, Inc. (NYSE:AMBQ) just released its latest quarterly results and things are looking bullish. The results overall were credible, with revenues of US$25m beating expectations by 17%. Statutory losses were US$0.50 per share, 18% below what the analysts had forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Taking into account the latest results, the consensus forecast from Ambiq Micro's five analysts is for revenues of US$121.8m in 2026. This reflects a substantial 49% improvement in revenue compared to the last 12 months. Per-share losses are expected to explode, reaching US$2.20 per share. Before this latest report, the consensus had been expecting revenues of US$100.8m and US$2.60 per share in losses. We can see there's definitely been a change in sentiment in this update, with the analysts administering a sizeable upgrade to this year's revenue estimates, while at the same time reducing their loss estimates. Check out our latest analysis for Ambiq Micro It will come as no surprise to learn thatthe analysts have increased their price target for Ambiq Micro 67% to US$70.20on the back of these upgrades. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Ambiq Micro, with the most bullish analyst valuing it at US$72.00 and the most bearish at US$69.00 per share. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth. One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Ambiq Micro's rate of growth is expected to accelerate meaningfully, with the forecast 70% annualised revenue growth to the end of 2026...
Investor releaseQuarter not tagged2026-05-13Ambiq Micro Q1 Earnings Call Highlights
MarketBeat
Ambiq Micro Q1 Earnings Call Highlights
Interested in Ambiq Micro, Inc.? Here are five stocks we like better. Ambiq Micro reported first-quarter 2026 results that beat expectations, with net sales up 59.3% year over year to $25.1 million as edge AI demand accelerated and a new major customer entered production. The company gave a strong second-quarter outlook, forecasting $31 million to $32 million in sales, or roughly 75% year-over-year growth, and said demand is being driven by multiple customer launches and broader adoption beyond wearables. Management said Ambiq is expanding into healthcare, industrial, smart home and building applications while advancing its Apollo and Atomiq product roadmap, with new products expected to support revenue growth and potentially improve profitability over time. Ambiq Micro (NYSE:AMBQ) said first-quarter 2026 results exceeded its expectations as demand for edge artificial intelligence accelerated across its customer base, with management pointing to strong product launch ramps, a new customer entering production and expanding use cases beyond wearables. Chief Executive Officer Humi Esaka said Ambiq began 2026 with “exceptional momentum,” citing rapid growth in the edge AI market and demand for the company’s ultra-low power SPOT platform. She said more than 80% of units shipped in the quarter were running AI algorithms, and that inventory levels remain lean as the company sees more expedited customer requests. → Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum “The market for Edge AI is growing rapidly and is outpacing our expectations from the start of the year,” Esaka said. She added that Ambiq expects momentum to continue through the rest of 2026. Chief Financial Officer Jeff Winzeler said first-quarter net sales were $25.1 million, up 59.3% year over year, driven by broad-based strength across the customer base. He said two customers showed particularly strong demand tied to new product launch ramps, while Ambiq also benefited from a new major customer that entered production during the quarter. → MercadoLibre Boldly Invests in Growth: Discount Deepens Non-GAAP gross profit rose 56.2% year over year to $11.6 million. Non-GAAP gross margin was 46.2%, down 90 basis points from a year earlier, which Winzeler attributed primarily to a nonrecurring credit in the prior-year quarter. Excluding that impact, he said non-GAAP gross margin increased 210 ba...
Investor releaseQuarter not tagged2026-05-13Full Transcript: Ambiq Micro Q1 2026 Earnings Call
Benzinga
Full Transcript: Ambiq Micro Q1 2026 Earnings Call
On Tuesday, Ambiq Micro (NYSE:AMBQ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. Access the full call at https://events.q4inc.com/attendee/507165301 Ambiq Micro Inc reported strong first-quarter 2026 financial results, with net sales of $25.1 million, a 59.3% year-over-year increase driven by demand for Edge AI solutions. Strategic expansion into non-wearable markets such as medical, industrial, and smart home sectors is gaining traction, expected to contribute significantly to revenue growth. The company anticipates a 75% year-over-year sales increase in the second quarter of 2026, supported by rising demand for Apollo 5 and diversification across new product lines. Ambiq Micro Inc's gross margin was 46.2%, with ongoing investments in R&D and SG&A to support product development and market expansion. Management highlighted strong momentum in Edge AI markets, with plans to accelerate growth through product innovations such as Apollo 340 and Atomic series, projecting meaningful revenue growth for 2026. OPERATOR Good morning and welcome to Ambic micro first quarter 2026 earnings conference call. As a reminder, this conference call is being recorded. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press Star one on your telephone keypad. To withdraw your question, please press Star one again. I'd now like to turn the call over to Ms. Charlene Wan, Ambic's Vice President of Corporate Marketing and Investor Relations. Charlene, please go ahead. Charlene Wan (Vice President of Corporate Marketing and Investor Relations) On today's call, Ambic CEO Humi Asaka will provide an overview of the Company's performance and strategy. CFO Jeff Winsler will then discuss the quarter's financial results and second quarter outlook. Following their remarks, Scott Hansen, Ambiq Micro Inc's Founder and cto, and Aaron Gracchian, EVP of Global Sales and Marketing, will join Humi and Jeff for Q and A. Our earnings release is available on the Investor Relations page of our website at www.ambig.com. we have also posted our earnings presentation on the Investor Relations section of our website. Befor...
Investor releaseQuarter not tagged2026-05-13Ambiq Micro Inc (AMBQ) Q1 2026 Earnings Call Highlights: Surging Sales and Strategic Growth ...
GuruFocus.com
Ambiq Micro Inc (AMBQ) Q1 2026 Earnings Call Highlights: Surging Sales and Strategic Growth ...
This article first appeared on GuruFocus. Release Date: May 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Ambiq Micro Inc (NYSE:AMBQ) reported net sales of $25.1 million for Q1 2026, marking a 59.3% year-over-year increase. The company is experiencing strong demand for its edge AI solutions, with more than 80% of units running AI algorithms. Ambiq Micro Inc (NYSE:AMBQ) is successfully diversifying its revenue stream, with its three largest customers accounting for a reduced percentage of sales compared to the previous year. The company expects net sales to grow approximately 75% year-over-year in the second quarter, driven by strong end-user demand and new customer production. Ambiq Micro Inc (NYSE:AMBQ) has a strong financial position with no debt and $204.5 million in cash and cash equivalents, providing flexibility for strategic investments. Non-GAAP gross margin decreased by 90 basis points year-over-year due to a non-recurring credit in Q1 2025. The company reported a non-GAAP net loss of $5 million for the quarter, with a non-GAAP net loss per share of $0.25. Operating expenses increased significantly, with non-GAAP R&D up 43.3% and SG&A expenses up 31.8% year-over-year. Ambiq Micro Inc (NYSE:AMBQ) anticipates continued pressure on gross margins due to industry-wide cost dynamics. The company is not yet profitable and requires further revenue growth to reach profitability, with expectations for this milestone potentially being pushed to 2028. Warning! GuruFocus has detected 4 Warning Sign with AMBQ. Is AMBQ fairly valued? Test your thesis with our free DCF calculator. Q: Could you provide an update on the percentage of your funnel that is non-wearables, and how much of Q1 revenue was consumer wearables versus medical, industrial, or smart home? A: Right now, about one quarter of our pipeline is non-wearables. In Q1, we grew 100% in the non-wearable market, and we expect to continue this growth trajectory. Q: With these strong results, you're rapidly approaching a $40 million quarter run rate. Can you provide an update on the timeline to profitability? A: At 46% margin, we need revenues of roughly $47 million a quarter to reach profitability. We are making significant investments in our product roadmap to pull in revenue streams, potentially achieving profitability in early 2028 or the seco...
TranscriptFY2026 Q12026-05-12FY2026 Q1 earnings call transcript
Earnings source - 57 paragraphs
FY2026 Q1 earnings call transcript
Good morning, welcome to Ambiq Micro 1st quarter 2026 earnings conference call. As a reminder, this conference call is being recorded. After today's prepared remarks, we will host a question and answer session. I'd now like to turn the call over to Ms. Charlene Wan, Ambiq's Vice President of Corporate Marketing and Investor Relations. Charlene, please go ahead.
On today's call, Ambiq's CEO, Fumihide Esaka, will provide an overview of the company's performance and strategy. CFO Jeff Winzeler will then discuss the quarter's financial results and second quarter outlook. Following their remarks, Scott Hanson, Ambiq's Founder and CTO, and Aaron Grassian, EVP of Global Sales and Marketing, will join Fumi and Jeff for Q&A. Our earnings release is available on the investor relations page of our website at www.ambiq.com. We have also posted our earnings presentation on the investor relations section of our website. Before I turn the call over to Fumi, I'd like to remind our listeners that during the course of this conference call, management will discuss non-GAAP financial measures. Reconciliations of these non-GAAP measures to their most directly comparable GAAP measures are included in our earnings release available on the company's investor relations website.
In addition, today's call will contain forward-looking statements representing management's beliefs and assumptions only as of the date made. Our most recent annual report on Form 10-K and other filings with the SEC provide more information on specific risks that may cause the actual results to differ materially from current expectations. Now it's my pleasure to turn the call over to Ambiq's CEO, Fumihide Esaka.
Good morning, everyone, and thank you for joining us. We have started 2026 with exceptional momentum. The market for edge AI is growing rapidly and is outpacing our expectations from the start of the year. Against this backdrop, our ultra-low power SPOT platform is driving market expansion, gaining share, and reinforcing Ambiq as a partner of choice in a fast-growing category. We expect this momentum to continue throughout the rest of the year. At the same time, our pipeline continued to grow and diversify, and we are investing strategically to further scale the business and extend our technology advantage. Turning to the first quarter performance, net sales exceeded guidance with strong year-over-year and sequential growth from the fourth quarter of 2025.
This performance was driven by broad-based demand for edge AI across our customer base, with more than 80% of units running AI algorithms, order ramps for the upcoming customer product launches, and the new customer entering production. Inventory level remains lean, and we are seeing an increasing number of expedited requests, which reinforces our view that demand is healthy across our end markets. For the second quarter, we expect net sales to grow approximately 75% year-over-year, with momentum continuing in the second half of the year. This outlook is supported by 4 key factors. First, strong and growing end user demand for edge AI solutions. Wearables continue to evolve from basic consumer products to more sophisticated health and wellness platforms. We are seeing continued diversification across form factors, including watches, display-less bands, rings, and eyewear.
Second, strong growth in Apollo5 as our customer upgrade to enable next generation edge AI capabilities while maintaining ultra-low power performance. Third, broader deployment of our solutions across customer portfolios with upcoming product launches and expansion into new form factors. Fourth, we expect a new scaled global customer to enter mass production this year. While wearables remains a key growth driver, adoption is expanding into healthcare, industrial, and smart home and buildings markets as customers deploy AI directly onto devices. Increasingly, end customers expect real-time insights and faster response time, driving the need to process more data directly at the edge. This rise of LLM-driven agents is accelerating this shift, increasing demand for contextual real-time intelligence at the edge and tighter integration between device data and the cloud.
Our solutions are purpose-built to support this evolution, positioning Ambiq as a partner of choice for leading players in the edge AI ecosystem. We're building on this foundation with focused action to expand into additional high-value markets and to develop new products that will further extend our power and performance advantage. Starting with diversification, our personal device business continued to grow and diversify. We have added multiple new customers and secured new design wins across emerging form factors, including display-less bands, smart eyewear, and rings. At the same time, customers are deploying more sophisticated edge AI capabilities on our platform, including a recently secured design win with one of our largest customers for a next-generation product line expected to enter production in 2027.
Beyond personal devices, our expansion into medical, industrial, and smart homes and buildings markets is gaining meaningful traction. We expect revenue from these segments to more than double in 2026. With our broad SoC platform, we offer a scalable and diverse portfolio that supports applications from entry-level designs to more advanced feature-rich use cases. As a result, Ambiq serves as a critical enabler of edge AI, allowing customer to select and to deploy the right solutions across a wide range of applications, including real-time health monitoring, intelligent audio, predictable maintenance, and smart sensing and automation. We're complementing this with a steady cadence of software tools that enhance edge AI capabilities with a focus on how customers capture, process, and derive value from data at the edge.
For example, by combining our ultra-low power hardware with our compressionKIT software, customers will be able to maintain multi-day battery life while storing large volumes of raw physical data and enabling real-time anomaly detection at the edge, expanding what is possible in next-generation medical devices. We are encouraged by the early traction we are seeing and believe Ambiq is well-positioned to deliver growth and diversification across customers and end market and high-value use cases. Looking ahead, we expect our expanding product roadmap to further accelerate this momentum. We continue to make progress on Apollo 340, Atomiq110, and Atomiq120, which are being developed in parallel to support strong customer demand. Atomiq110 remains on track for tape-out towards the end of this year, with initial customer ramp in late 2027.
For Atomiq120, we are actively engaged with several potential alpha customers and are encouraged by the strong interest we are receiving, especially in smart glasses, where customers are seeking the combination of performance and ultra-low power that Atomiq is designed to deliver. Apollo 340 is also generating meaningful traction, with multiple customers expressing interest driven by its compelling price-to-value positioning. We see 340 as an important enabler to expand into higher volume and more diverse opportunities, complementing the higher performance Atomiq family and supporting our strategy to scale across a wider range of edge AI applications. In closing, we have strong momentum across the business and believe we are well-positioned to deliver meaningful revenue growth this year. We continue to execute our strategic priorities and strengthen our leadership in ultra-low power semiconductor solutions as we expand into new edge AI markets and advance our product roadmap.
The edge AI opportunity ahead is tremendous, and we are confident in our ability to capture it to drive long-term growth and value creation. With that, I will turn it over to Jeff to cover the financials.
Thank you, Fumi, and good morning, everyone. We delivered a strong start to the year, with first quarter net sales and gross profit up both sequentially from the fourth quarter of 2025 and year-over-year, well ahead of our expectations. Looking ahead, we expect a meaningful acceleration in the second quarter as well, strengthening our confidence in driving meaningful growth for the full year of 2026. Along the way, we are making progress in diversifying our business. Our three largest customers accounted for 86% of our sales in the first quarter of 2025. Those same three customers accounted for approximately 71% of our first quarter 2026 sales, indicating that we are successfully diversifying our revenue stream to new customers and markets. Turning to our first quarter financial results.
We delivered net sales of $25.1 million, increasing 59.3% year-over-year, driven by broad-based strength across our customer base. We saw particularly strong demand from 2 customers supporting new product launch ramps, we also benefited from the addition of a new major customer that entered production during the quarter. Sales to end customers in China were 13.7% of total net sales, compared to 6.2% in the prior-year period. This increase was primarily driven by customer programs where our technology is enabling higher value edge AI functionality. Non-GAAP gross profit increased 56.2% year-over-year to $11.6 million. Q1 2026 non-GAAP gross margin of 46.2% was down 90 basis points year-over-year, primarily due to a Q1 2025 non-recurring credit.
Excluding this one-time impact, non-GAAP gross margin increased 210 basis points year-over-year. Turning to operating expense, non-GAAP R&D was $10.1 million, up 43.3% year-over-year, reflecting accelerated investments to support product development both across our Apollo and Atomiq platforms. Non-GAAP SG&A expenses were $8.1 million, up 31.8% year-over-year, driven by increased spending for go-to-market capabilities and public company infrastructure. Other income was $1.5 million, up $1.1 million year-over-year due to interest earned on balance sheet cash. Fourth quarter non-GAAP net loss was $5 million, a $200,000 improvement year-over-year. Non-GAAP net loss per share was $0.25. We ended the quarter with no debt and $204.5 million in cash and cash equivalents.
Our strong financial position provides the flexibility to invest in product development, software, and go-to-market initiatives to support our strategic growth priorities. Now turning to our outlook. For the second quarter, we expect net sales in the range of $31 million-$32 million, reflecting the trends that Fumi covered earlier. Non-GAAP gross margin between 45%-46%, driven by the continued progress on yield improvements and continued Apollo5 scaling. Non-GAAP operating expense of $21 million-$22 million, reflecting investments to support product development and our strategic growth priorities, including $1.7 million related to IP purchases this quarter. Lastly, we expect non-GAAP loss per share of $0.29-$0.23 based on a weighted average share count of 21.38 million shares outstanding. As we think about the trajectory of our business, we have clear visibility, and we're confident in continued momentum.
Q2 outlook reflects the timing of multiple customer launches coming into production at the same time. Importantly, we view that as a step up in the baseline rather than a peak as those programs continue to scale and are complemented by additional ramps behind them. While we continue to expect seasonality in the fourth quarter, we expect year-over-year second half net sales growth to be similar to first half. We continue to expect gross margins to be roughly flat year-over-year as yield improvements are offset by broader industry cost dynamics. We continue to expect operating expense of approximately $85 million for the year, reflecting increases to engineering headcount, utilizing contract engineering to provide flex in our model for both upside and downside, and $7 million-$10 million of IP purchases necessary for product development.
With that, I'll turn the call back over to Fumi before we open the line for Q&A.
Edge AI adoption is accelerating. Our pipeline is expanding and our technology continued to make us a partner of choice to enable on-device intelligence. As we execute against our roadmap and scale into new markets, we remain focused on driving sustained top-line growth, expanding our leadership in ultra-low power edge AI, and delivering long-term value for our shareholders. With that, I will open the call to questions. Operator, please go ahead.
Thank you. We will now begin the question and answer session. If you would like to ask a question, please press star one on your telephone keypad. To withdraw your question, please press star one again. Please pick up your handset when asking a question, and if you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Liam Farr from BofA Securities. Your line is now open.
Hi. Good morning. Thanks for taking my questions. Could you provide us an update on the percentage of your funnel that is non-wearables, and how much of 1Q revenue was consumer wearables versus medical, industrial or in smart home?
Right now, we still continue to have a funnel of non-wearables about one quarter of our pipeline. We continue to have a strong growth in, like I said, in Q1, we grew 100% in a non-wearable market, and we expect to continue to grow non-wearable market as fast as we've been doing.
Great. Thank you. With these strong results, you're kind of rapidly approaching that $40 million a quarter run rate. Could you provide us an update on the timeline to profitability? Will maybe a higher OpEx burn and maybe, you know, gross margin remaining roughly flat still, you know, keep profitability only until 2028, or is there potential for that to be pulled forward?
Jeff?
Yeah, Liam. So a couple questions there. The first in terms of when do we get to that profitability, if you quarterize the guidance that we gave for spending, we're spending roughly $21 million a quarter at 46% margin, which is what we just achieved in Q1. You need revenues roughly $47 million a quarter to get to that point. You know, we just guided the quarter a little bit below that, so we've got a ways to go. That said, we made big investments in terms of accelerating our product roadmap, namely our 110 product and our 340 product. The purpose of those investments is to pull that revenue stream in, which is necessary for us to get to that revenue level.
We're hopeful that that investment will allow us to pull our cash flow breakeven and our P&L profitability point from, call it, mid 2028 into early 2028 or potentially into the second half of 2027.
Thank you.
Your next question comes from the line of Tore Svanberg from Stifel. Your line is now open.
Thank you, and congratulations on the momentum here. Maybe to follow up on the initial question there as far as the diversification, you talked about some of the percentages a wee bit. Can you talk about some of the use cases out of wearables that's driving that doubling?
let me give you some of the examples, Tore. definitely medical market is growing, the one of the fastest one outside of wearable, ECG, glucose monitoring. we have bike computing, smart pens, battery monitors, remote controls, livestock tracking. I mean, we're seeing a lot of AI adoption outside of wearables, so we're very excited.
Very good. As my follow-up, you mentioned the new customer introduction this quarter. I assume that's not part of the three largest. Is there a chance that this particular customer will become more than 10% of revenues this year?
There's a possibility that they will.
Very good. Thank you.
A reminder, if you would like to ask a question, to please press star one. Your next question comes from the line of Quinn Bolton from Needham. Your line is now open.
Hey, guys. Congratulations on the nice results and outlook. Jeff, just wanted to make sure I sort of caught your comments about how you're thinking for the full year. I think you said you would expect similar growth rates in the second half on a year-over-year basis that you saw in the first half. Looks like the first half, you were up about 68% over the first half of 2025. It sounds like you're thinking about sort of a similar 65% growth second half of 2026 over second half 2025, but just wanna make sure I heard your comments correctly.
Yeah, that's correct, Quinn. You know, I think as we look at the business outlook, clearly we had strong Q1 results. We've guided a higher Q2. I think the business model, when you think about the business model, basically just the level has gone up. We've set kind of a new baseline, if you will, in terms of how to think about 2026. We also made the comment in the call about we still expect seasonality in the fourth quarter, so the shape of the curve is pretty much in line with what we would expect.
Got it. The second question is, your comments about gross margin, you know, being sort of flattish half-over-half sound like it implies a little bit of a tick down in Q3, Q4. I know you've got obviously higher revenue in the second half. You probably have mix shift to higher ASP devices like Apollo5. Just wondering, it sounds like the input price increases are, you know, the biggest factor pressuring margins. Wanted to confirm that. Second, given that you're not alone in seeing these input price increases, do you have the ability to pass along some of those input price increases along to customers to try to protect margins over a, you know, intermediate to longer term?
Sure. a couple of answers there. When we think about margins, there's 2 real dynamics that are happening in our business. First is we've done a lot of work to increase our yields across the product line, specifically, Apollo5, which is a ramping process for us. We've done a lot of work to try and pull in some of that yield improvement and make our cost base better. However, we're tempering that expectation because there are industry-wide dynamics around substrate costs, piece part costs, and other things that are out of our control that will potentially negate some of that good news. We think about that margin curve as relatively flat, you know, plus or minus 1 point from where we're at today.
In terms of our ability to pass on pricing to customers, I think one of the main opportunities we have there is we have a lot of demand for our product, and customers are asking us to pull in volumes pretty significantly. You know, the cost of doing that expediting material is certainly something that we would expect our customers to share in terms of paying for that type of expedite. In terms of actual ASP uplift, you know, we're being very strategic about where we exercise any potential ASP uplift to end customers. We still have to be very competitive. We still want to win business, and I think we can see that we're doing a pretty good job of landing new business with our pricing policy.
Less for either Fumi or Jeff, just you talked multiple times about the expedites you're seeing. Are you getting enough supply from TSMC and your OSAT partners, or do you think you're leaving any demand on the table given that acceleration in expedites?
You know, we have a very strong partnership from the front and the back end of the manufacturing. We are very fortunate to have a great partner to support our customers. However, the market is growing much faster than we expected. Sometimes we get such a short lead time demand increase, which physically sometimes is, you know, the most difficult to do. Some of the order we just can't meet because of the too short of lead time. As long as it's in the timeframe that, you know, normal lead time, we'll be able to support, and we expect us to be able to support these customers quarter after quarter.
Excellent. Thank you.
Your next question comes to the line of Tore Svanberg from Stifel. Tore, your line is now open.
Yeah, thank you. I just had two quick follow-ups. First of all, you announced a new product called compressionKIT not too long ago. I'm just wondering, is that a product that you will sell exclusively with your own products, or is that basically available to, you know, any other system that contains other components?
Yeah, for the moment, it's something that will be restricted to our products. Certainly long term, it's something that we could look at pairing with other products. We feel that the combination of Apollo plus compressionKIT is a situation of, you know, 1 plus 1 equals 3 rather than 1 plus 1 equals 2. Yeah. We'll restrict it for the moment to Ambiq products.
That's very helpful, Scott. My last question is on Apollo 340. You gave some sampling timelines. Anything on Apollo 340 as far as when we should start to expect some material revenue?
Yeah. Just to maybe reiterate, rough timeline is it's in design right now. We expect to sample in the first half of next year. We expect initial customer ramps toward the end of next year and then more meaningful revenue in 2028. I think what everyone's gonna like about this product is it's gonna be quite a bit more diverse in terms of the types of customers that we're serving with it. You know, think everything from some of the medical products that Fumi alluded to earlier, to industrial sensors and smart home sensors, smart grid sensors, that sort of thing. As well, we'll be serving wearables.
Think certain form factors like smart rings as being great targets for an Apollo 340. A really nice diversity of customers there. We're excited about where that will go.
Sounds good. Thanks again, Scott.
Thank you.
Your next question is a follow-up from Liam Farr from Bank of America Securities. Liam, your line is now open.
Hi. Thanks for letting me jump back in. I guess for 2026, and this step up, how do you see kind of this unit versus ASP mix kind of driving that growth? Is this step up more from the new programs and kind of unit-based, or is this combination with these new programs also providing a lot, you know, a little bit more of?
Premium, you know, Apollo 5 mix to kind of drive some of the ASP as well.
Liam. The answer is we're expecting uplift in both, but clearly, you know, with Q1 being 56% above where we were in the same quarter last year and the strong guidance we gave in Q2, the predominant reason that we're up is because of unit shipments. That said, we're very happy with the status of our Apollo5 ramp. It is starting to contribute more and more each quarter to our revenue profile, and it gives us some ASP uplift in the overall business.
Makes sense. I guess as my follow-up, can you maybe just provide an update on your pricing strategy? I think, you know, previously it's been every generation is driven by 1.5x-2x content uplift, and that's kind of driven, you know, a pricing premium in a similar ballpark. I guess with this, you know, really strong demand environment, it would make sense to me to see kind of more pricing benefit from your, you know, Apollo5 and potentially even Atomiq kind of platforms, given how much benefit they're gonna be giving your customers versus, you know, the previous generation and how fast you guys are innovating.
Yeah, I mean, certainly as we continue to proliferate Apollo 5 and Apollo 3 and Apollo 4 to multiple different markets, and enable end customer edge AI to happen, we would expect to see a higher value proposition and better pricing for those products. I think, you know, in general, when we think about the pricing or strategic pricing going forward, we're certainly looking at opportunities where we could maximize our ASPs across different customers and markets.
Okay, thank you very much.
There are no further questions at this time, and this concludes today's call. Thank you for attending. You may now disconnect.
Investor releaseQuarter not tagged2026-05-07Applied Materials (AMAT) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
Applied Materials (AMAT) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Applied Materials (AMAT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 14. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. This maker of chipmaking equipment is expected to post quarterly earnings of $2.68 per share in its upcoming report, which represents a year-over-year change of +12.1%. Revenues are expected to be $7.69 billion, up 8.4% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 1.15% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive...
Investor releaseQuarter not tagged2026-05-05Will Ambiq Micro, Inc. (AMBQ) Report Negative Earnings Next Week? What You Should Know
Zacks
Will Ambiq Micro, Inc. (AMBQ) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Ambiq Micro, Inc. (AMBQ) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 12. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This company is expected to post quarterly loss of $0.36 per share in its upcoming report, which represents a year-over-year change of +98.1%. Revenues are expected to be $21.5 million, up 36.7% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 1.69% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for...
Investor releaseQuarter not tagged2026-04-28Ambiq Micro to Report First Quarter 2026 Financial Results
Business Wire
Ambiq Micro to Report First Quarter 2026 Financial Results
AUSTIN, Texas, April 28, 2026--(BUSINESS WIRE)--Ambiq Micro, Inc. (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced that it will report its first quarter 2026 financial results on Tuesday, May 12, 2026 before the market opens. The Company will host a conference call at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) to discuss the results. Analysts and investors are invited to join the live conference call using the following information: Date: Tuesday, May 12, 2026 Time: 7:30 a.m. Central Time (8:30 a.m. Eastern Time) Webcast Link: https://events.q4inc.com/attendee/507165301 Conference Call Number: (833) 461-5787 International Call Number: +1 (585) 542-9983 Conference ID: 507165301 Additionally, a live public webcast of the earnings conference call can be accessed on the Events & Presentations section of the Company’s Investor Relations website. For those unable to join the live broadcast, a replay of the webcast will be available on Ambiq’s Investor Relations website for approximately one year. About Ambiq Headquartered in Austin, Texas, Ambiq’s mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Ambiq enables its customers to deliver AI compute at the edge where power consumption challenges are the most severe. Ambiq’s technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT®), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. Ambiq has powered over 290 million devices to date. For more information, visit www.ambiq.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260428639069/en/ Contacts Company Contact: Charlene Wan VP of Corporate Marketing and Investor Relations P: +1-512-879-2850 E: [email protected] Investor Relations Contact: Teneo Christina Coronios E: [email protected]
Investor releaseQuarter not tagged2026-03-06Ambiq Micro, Inc. Q4 2025 Earnings Call Summary
Moby
Ambiq Micro, Inc. Q4 2025 Earnings Call Summary
Successfully executed a strategic pivot to prioritize high-value customers who utilize ultra-low-power technology for edge AI, significantly reducing exposure to feature-neutral markets in Mainland China. Achieved record annual gross profit despite lower net sales, validating the shift toward higher-margin, AI-driven applications where over 80% of shipped units now run AI algorithms. Attributed Q4 outperformance to a combination of strong end-market demand, broader adoption across customer portfolios, and a migration toward the more advanced Apollo 5 platform. Expanded the design funnel into diversified, long-cycle markets including medical, industrial, and smart home sectors to reduce long-term reliance on the wearables market. Leveraged the proprietary SPOT platform to enable sophisticated AI capabilities in power-constrained devices, such as real-time health monitoring and predictive industrial maintenance. Secured and began ramping a new scaled global customer, which is expected to contribute significantly to volume growth throughout 2026 and into 2027. Management anticipates 2026 net sales to exceed $100 million, driven by an inflection point in customer forecasts and new product launches across diverse form factors like smart rings and eyewear. Accelerating the product roadmap by starting development of Apollo 340 and Atomic 120 families concurrently to capture immediate demand for mass-market and high-end edge AI. Projecting a $30 million increase in operating expenses for 2026 to fund expanded engineering headcount and critical IP acquisitions necessary for the transition to FinFET-based products. Guidance for 2026 assumes a non-linear spending pattern, with heavy R&D and IP investments concentrated in the second and third quarters to support upcoming product tape-outs. Expects gross margins to remain in the 44% to 45% range, balancing yield improvements from the Apollo 5 ramp against potential industry-wide supply chain cost pressures in the second half of the year. Announced 'Atomic,' the first SPOT family built on a 12nm FinFET process, capable of operating at 300 millivolts—the lowest voltage in company history. Mainland China revenue exposure decreased to 8.6% of net sales in Q4 2025, down from 50% in 2024, following the deliberate exit from low-margin commodity segments. Identified potential headwinds from increasing fabless semiconductor costs...
Investor releaseQuarter not tagged2026-03-06Ambiq Micro Q4 Earnings Call Highlights
MarketBeat
Ambiq Micro Q4 Earnings Call Highlights
Ambiq delivered its highest quarter of 2025 with net sales of $20.7 million (up 2% YoY, 14.2% sequentially) and expanded non-GAAP gross margin to 45.5%, driven by a favorable product mix and broader adoption of Apollo5. Management expects 2026 to be a strong growth year and sees a “clear path to more than $100 million” in revenue, guiding Q1 net sales to $21–$22 million with non-GAAP gross margin of 44%–45%. Operating expense will increase sharply—about $30 million higher in 2026 (including $7–$10 million of IP purchases) to accelerate Apollo and Atomic development, while the company has no debt and roughly $217.1 million in cash after a $76.8 million follow-on to fund growth. Interested in Ambiq Micro, Inc.? Here are five stocks we like better. Ambiq Micro (NYSE:AMBQ) reported fourth-quarter and full-year fiscal 2025 results that management said reflected accelerating demand for edge AI, improved business mix, and benefits from the company’s strategic repositioning away from “efficiency-focused, feature-neutral” customers. Executives also outlined a 2026 outlook calling for strong revenue growth alongside significantly higher operating expense as the company accelerates development across its Apollo and Atomic product families. CEO Fumihide Esaka said the company delivered its highest net sales quarter of 2025 in the fourth quarter, exceeding guidance as end-user demand outpaced customers’ expectations and led to incremental expedited orders late in the quarter. He attributed the sequential net sales increase from the third quarter to three factors: strong end demand for customers’ products, broader adoption of Ambiq solutions within customer portfolios, and customers upgrading to Apollo5 for more advanced edge AI functionality. → Uber and Joby Aviation Team Up: Game Changer or Hype? CFO Jeff Winzeler reported fourth-quarter net sales of $20.7 million, up 2% year over year and up 14.2% sequentially. Non-GAAP gross profit rose 75.5% year over year to $9.4 million, and non-GAAP gross margin expanded to 45.5%, which Winzeler said was driven by a more favorable product mix and higher sales to customers deploying multiple edge AI capabilities on Ambiq’s SPOT platform. Winzeler also highlighted that mainland China accounted for 8.6% of net sales in the fourth quarter, down from 50% in the fourth quarter of 2024, reflecting the company’s shift in customer mix. Fou...
Investor releaseQuarter not tagged2026-03-05Ambiq Reports Fourth Quarter and Full Year 2025 Financial Results
Business Wire
Ambiq Reports Fourth Quarter and Full Year 2025 Financial Results
Full Year 2025 net sales of $72.5 million, with sequential growth in net sales in every quarter of the year Fourth quarter net sales of $20.7 million exceeded guidance and marked the highest quarterly net sales of 2025 driven by accelerated customer demand and strong operational execution Fourth quarter GAAP gross margin of 42.7%; non-GAAP gross margin of 45.5%, reflecting successful scaling across higher-value customers and broader market diversification Expect strong first quarter net sales of $21.0 million to $22.0 million, reflecting growing momentum in advanced edge AI adoption AUSTIN, Texas, March 05, 2026--(BUSINESS WIRE)--Ambiq Micro, Inc. ("Ambiq") (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the fourth quarter and full year 2025. Full Year 2025 and Recent Highlights Strong performance on accelerating demand for edge AI solutions: Fourth quarter net sales were ahead of guidance with sequential net sales growth in every quarter of 2025. Continued AI-driven margin expansion: Delivered year-over-year margin expansion in the fourth quarter and full year 2025, driven by a shift toward higher-value revenue streams and greater geographic diversification. Full year 2025 gross profit was the highest in Company history. Advanced ultra-low-power AI silicon innovation: Unveiled Atomiq®, the world’s first ultra-low-power NPU SoC built on Ambiq’s SPOT® architecture. Launched three new Apollo variants, expanding our portfolio and enabling edge AI capabilities across a broader range of devices and end-markets. Expanded industrial edge AI presence: Announced partnership with RONDS to enable large-scale deployment of always-on, battery-powered AI sensors for heavy industrial applications. Recognized as an award-winning edge AI platform: neuralSPOT® software development kit (SDK) was honored as EDN’s 2025 Product of the Year, highlighting Ambiq’s differentiated approach to accelerating ultra-low-power edge AI development and deployment across key end markets. Received strong market interest in Ambiq’s strategy and growth opportunity: Ambiq completed an upsized initial public offering and a follow-on offering, generating $102.7 million and $76.8 million in net proceeds, respectively. Strengthened leadership and governance: Ambiq welcomed Dr. Bernard (Bernie) Banks to its Board of Directo...
Investor releaseQuarter not tagged2026-03-05Ambiq Micro (AMBQ) Q4 2025 Earnings Transcript
Motley Fool
Ambiq Micro (AMBQ) Q4 2025 Earnings Transcript
Image source: The Motley Fool. Mar. 5, 2026, 8:30 a.m. ET Chief Executive Officer — Fumihide Esaka Chief Financial Officer — Jeffrey Winzeler Founder & Chief Technology Officer — Scott Hanson EVP, Global Sales and Marketing — Aaron Grashian Charlene Wan: On today’s call, Ambiq Micro, Inc.’s CEO, Fumihide Esaka, will provide an overview of the company’s performance and strategy. CFO, Jeffrey Winzeler, will then discuss the quarter’s financial results and 2026 outlook. Following their remarks, Scott Hanson, Ambiq Micro, Inc.’s Founder and CTO, and Aaron Grashian, EVP of Global Sales and Marketing, will join Fumi and Jeff for Q&A. Our earnings release is available on the Investor Relations page of our website at www.ambiq.com. We have also posted our earnings presentation on the Investor Relations section of our website. Before I turn the call over to Fumi, I would like to remind our listeners that during the course of this conference call, management will discuss non-GAAP financial measures. Reconciliations of these non-GAAP measures to their most directly comparable GAAP measures are included in our earnings release available on the company’s Investor Relations website. In addition, today’s call will contain forward-looking statements, representing management’s beliefs and assumptions only as of the date made. Our most recent annual report on Form 10-Q and other filings with the SEC provide more information on specific risks that may cause the actual results to differ materially from current expectations. And now it is my pleasure to turn the call over to Ambiq Micro, Inc.’s CEO, Fumihide Esaka. Fumihide Esaka: Good morning, everyone, and thank you for joining us. 2025 was a strong year for Ambiq Micro, Inc., defined by disciplined execution and accelerating demand for edge AI across our end markets. Our performance reflects both share gains and market expansion as we enable AI on more devices across more markets and in a growing number of use cases. We are entering 2026 with strong momentum. Based on current demand indicators, we expect outsized top-line growth. We remain confident in our long-term opportunity as we partner with customers to advance their edge AI roadmaps and deliver sustained growth. Starting with Q4 performance, we delivered our highest net sales quarter of 2025, exceeding guidance. End-user demand outpaced our customers’ expectations, res...

